The Q1 result was announced after market hours yesterday, 5 August 2015.

Meanwhile, the S&P BSE Sensex was down 5.70 points or 0.02% at 28,217.38.

On BSE, so far 2.95 lakh shares were traded in the counter as against average daily volume of 28,227 shares in the past one quarter.

The stock hit a high of Rs 200.45 so far during the day, which is a record high for the counter. The stock hit a low of Rs 184.50 so far during the day. The stock had hit a 52-week low of Rs 130.10 on 13 August 2014.

The stock had outperformed the market over the past one month till 5 August 2015, surging 12.45% compared with Sensex's 0.46% rise. The scrip had also outperformed the market in past one quarter, jumping 12.96% as against Sensex's 2.85% rise.

The mid-cap company has equity capital of Rs 17.78 crore. Face value per share is Re 1.

FDC is a pharmaceutical research and development company, which specializes in the areas of synthetics (basic drugs), nutraceuticals, formulations and biotechnology products.